| Title |
Aripiprazole for autism spectrum disorders (ASD)
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, May 2012
|
| DOI | 10.1002/14651858.cd009043.pub2 |
| Pubmed ID | |
| Authors |
Ching, Heidi, Pringsheim, Tamara |
| Abstract |
Autism spectrum disorders (ASD) include Autistic Disorder, Asperger's Disorder and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). Irritability related to ASD has been treated with antipsychotics. Aripiprazole, a third generation atypical antipsychotic, is a relatively new drug that has a unique mechanism of action different from other antipsychotics. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 9% |
| Mexico | 1 | 9% |
| United Kingdom | 1 | 9% |
| Unknown | 8 | 73% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 91% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| Spain | 1 | <1% |
| France | 1 | <1% |
| Unknown | 110 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 19% |
| Student > Bachelor | 14 | 12% |
| Other | 11 | 10% |
| Student > Master | 11 | 10% |
| Student > Doctoral Student | 8 | 7% |
| Other | 29 | 26% |
| Unknown | 19 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 35% |
| Psychology | 15 | 13% |
| Agricultural and Biological Sciences | 7 | 6% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Neuroscience | 5 | 4% |
| Other | 18 | 16% |
| Unknown | 24 | 21% |